Dark

SCNI
Scinai Immunotherapeutics Ltd.
stock NASDAQ ADR

At Close

Sep 2, 2026 3:59:56 PM EDT

2.35USD-4.472%(-0.11)1,535,275

1.99Bid 2.90Ask 0.91Spread

Pre-market

Aug 31, 2026 9:28:30 AM EDT

2.50USD+1.626%(+0.04)0

After-hours

Sep 2, 2026 4:59:30 PM EDT

2.14USD-8.936%(-0.21)842,295

OverviewHistoricalExchangesShortsTrends

open chart

Market Cap

1.59M

Headquarters

Po Box 4143 14 Einstein Street, Ness Ziona, Israel

Industry

Research and Development in Biotechnology (except Nanobiotechnology)

Last Split

Aug 21, 20261for10reverse

SCNI Stats

Avg. Vol. 10 Day

139,242

Avg. Vol. 30 Day

73,289

Market Cap

1,592,315

Shares Out.

677,581

On/Off Exchange

38%/62%

6 Month Beta

1.64

1 Year Beta

1.88

2 Year Beta

0.57

3 Year Beta

0.92

52 Week Low

2.15

52 Week High

16.80

SMA50

2.60

SMA200

6.11

1 Week

-18.12%

1 Month

-13.92%

3 Month

-50.94%

6 Month

-72.36%

1 Year

-84.74%

2 Year

-93.89%

Profile

biondvax (nasdaq: bvxv) is an innovative biopharmaceutical company developing a universal flu vaccine, designed to provide multi-season and multi-strain protection against most human influenza virus strains, including both seasonal and pandemic flu strains. biondvax's technology utilizes a unique, proprietary combination of conserved epitopes from influenza virus proteins to activate the immune system for a cross-protecting and long-lasting effect.

SCNI Stock Summary

Scinai Immunotherapeutics Ltd. (NASDAQ:SCNI) stock price today is $2.35, and today's volume is 1,535,275. SCNI is down -4.472% today. The 30 day average volume is 73,289. SCNI market cap is 1.59M with 677,581 shares outstanding.

.dark-mode .tvkQMF{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .tvkQMF{ color: #333333; background-color: white; border: 2px solid #333333; }SCNIScinai Immunotherapeutics Ltd.stock NASDAQ ADR

SCNI Stock Summary

SCNI
Scinai Immunotherapeutics Ltd.
stock NASDAQ ADR